C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 53 000 KRW 0.76% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note

Celltrion Pharm Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celltrion Pharm Inc
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Celltrion Pharm Inc
KOSDAQ:068760
Net Income
â‚©16.5B
CAGR 3-Years
-26%
CAGR 5-Years
81%
CAGR 10-Years
13%
Yuhan Corp
KRX:000100
Net Income
â‚©162.4B
CAGR 3-Years
19%
CAGR 5-Years
30%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Income
-â‚©35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Net Income
â‚©103.3B
CAGR 3-Years
24%
CAGR 5-Years
44%
CAGR 10-Years
16%
Hanmi Pharm Co Ltd
KRX:128940
Net Income
â‚©181.6B
CAGR 3-Years
26%
CAGR 5-Years
34%
CAGR 10-Years
16%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Income
â‚©10.8B
CAGR 3-Years
167%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
No Stocks Found

Celltrion Pharm Inc
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 841 full-time employees. The company went IPO on 2006-02-03. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company also provides ethical drugs and over-the-counter (OTC) drugs. The firm distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Intrinsic Value
17 592.39 KRW
Overvaluation 67%
Intrinsic Value
Price
C

See Also

What is Celltrion Pharm Inc's Net Income?
Net Income
16.5B KRW

Based on the financial report for Sep 30, 2024, Celltrion Pharm Inc's Net Income amounts to 16.5B KRW.

What is Celltrion Pharm Inc's Net Income growth rate?
Net Income CAGR 10Y
13%

Over the last year, the Net Income growth was -38%. The average annual Net Income growth rates for Celltrion Pharm Inc have been -26% over the past three years , 81% over the past five years , and 13% over the past ten years .

Back to Top